We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GVK Biosciences and Crelux set up Fragment-based Drug Discovery Platform to Deliver Lead Molecules

News   Jan 30, 2009

 
GVK Biosciences and Crelux set up Fragment-based Drug Discovery Platform to Deliver Lead Molecules
 
 
 

RELATED ARTICLES

Concern Over Fake ISO 9001 Accreditation of Chinese Companies

News

A study concludes that fake ISO 9001 quality certificates are very widespread across Chinese companies and that the certification processes of the auditing companies lack credibility.

READ MORE

Drug Suppresses Formation of Metastases

News

The most deadly aspect of breast cancer is metastasis. It spreads cancer cells throughout the body. Researchers have now discovered a substance that suppresses the formation of metastases.

READ MORE

Protein Prods Cancer-fighting T Cells

News

A new protein has been created that mimics the action of a key immune regulatory protein, interleukin 2 (IL-2). IL-2 is a potent anticancer drug and an effective treatment for autoimmune disease, but its toxic side effects have limited its clinical usefulness.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE